ANXA1 and neoplasm: During chemotherapy, activation of the FPR1/annexin-1 axis induced interactions with dying tumor cells and resulted in T cell activation, but migration of DCs to the tumor site was not affected by the activation of formyl peptide receptor 1 [169].